Page 335 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 335

18
                                                                                                       P
                                                                                                          T
                                                                                                             E
                                                                                            C
                                                                                               H
                                                                                                   A
                                                                                                                 R
                    The Eicosanoids:

                    Prostaglandins,


                    Thromboxanes,


                    Leukotrienes, & Related


                    Compounds




                                                                             *
                    John Hwa, MD, PhD, & Kathleen Martin, PhD










                       C ASE  STUD Y

                       A 40-year-old woman presented to her doctor with   pulmonary pressures, and right ventricular enlargement.
                       a 6-month history of increasing shortness  of  breath.   Cardiac catheterization confirmed the severely elevated
                       This was associated with poor appetite and ankle swell-  pulmonary pressures. She was commenced on appropri-
                       ing. On physical examination, she had elevated jugular   ate therapies. Which of the eicosanoid agonists have been
                       venous distention, a soft tricuspid regurgitation murmur,   demonstrated to reduce both morbidity and mortality in
                       clear lungs, and mild peripheral edema. An echocardio-  patients with such a diagnosis? What are the modes of
                       gram revealed tricuspid regurgitation, severely elevated   action?





                    The eicosanoids are oxygenation (oxidation) products of poly-  ARACHIDONIC ACID & OTHER
                    unsaturated 20-carbon long-chain fatty acids (eicosa, Greek   POLYUNSATURATED PRECURSORS
                    for “twenty”). They are ubiquitous in the animal kingdom and
                    are also found—together with their precursors—in a variety of   Arachidonic acid (AA), or 5,8,11,14-eicosatetraenoic acid, the
                    plants. They constitute a very large family of compounds that   most abundant of the eicosanoid precursors, is a 20-carbon (C20)
                    are highly potent and display an extraordinarily wide spectrum   fatty acid containing four double bonds (designated C20:4–6).
                    of important biologic activities. Thus, their specific receptors,   The first double bond in AA occurs at 6 carbons from the methyl
                    receptor ligands, and enzyme inhibitors, and their plant and   end, defining AA as an omega-6 fatty acid. AA must first be released
                    fish oil precursors, are therapeutic targets for a growing list of   or mobilized from the sn-2 position of membrane phospholipids
                    conditions.                                          by one or more lipases of the phospholipase A  (PLA ) type
                                                                                                               2
                                                                                                                     2
                                                                         (Figure 18–1) for eicosanoid synthesis to occur. The phospho-
                                                                                 superfamily consists of 16 groups (over 30 isoforms),
                                                                         lipase A 2
                    * The authors thank Emer M. Smyth, PhD, and Garret A. FitzGerald, MD,   with at least three classes of phospholipases contributing to ara-
                    for their contributions to previous editions of this chapter.  chidonate release from membrane lipids: (1) cytosolic (c) PLA ,
                                                                                                                         2

                                                                                                                       321
   330   331   332   333   334   335   336   337   338   339   340